Kawachinagano, Japan

Osamu Sampei

This inventor holds 2 USPTO granted patents. Top assignee: Nihon Nohyaku Co., Ltd.. Active years: 2001-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Osamu Sampei

Introduction

Osamu Sampei is a notable inventor based in Kawachinagano, Japan. He has made significant contributions to the field of agrohorticultural science, particularly through his innovative patents. With a total of 2 patents, Sampei has established himself as a key figure in his industry.

Latest Patents

Sampei's latest patents include the development of 1,2,3-Thiadiazole derivatives or salts thereof, which serve as an agrohorticultural disease controller. His work on the method for using these derivatives showcases his commitment to advancing agricultural technology. The specific 1,2,3-thiadiazole derivative he has developed is represented by a general formula (I) or a salt thereof, highlighting the technical nature of his inventions.

Career Highlights

Osamu Sampei is currently employed at Nihon Nohyaku Co., Ltd., a company known for its focus on agricultural chemicals and solutions. His role at the company allows him to apply his innovative ideas in practical settings, contributing to the development of effective agricultural products.

Collaborations

Throughout his career, Sampei has collaborated with esteemed colleagues such as Kenji Tsubata and Tsutomu Nishiguchi. These partnerships have likely enhanced his research and development efforts, leading to successful innovations in agrohorticultural disease control.

Conclusion

Osamu Sampei's contributions to the field of agrohorticulture through his patents and collaborations demonstrate his dedication to innovation. His work continues to impact the agricultural industry positively, showcasing the importance of inventive minds in addressing modern challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…